Skip to main content

Table 2 Prevalence of coronary heart diseases across glycemic categories, by gender: Tehran Lipid and Glucose Study (phase IV: 2008–2011)

From: Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008–2011

 

Men

Women

Case/Total

Crude prevalence % (95% CI)

Age-standardized prevalence a

% (95% CI)

Case/Total

Crude prevalence % (95% CI)

Age-standardized prevalence a

% (95% CI)

NFG/NGT

139/1891

7.35 (6.17–8.53)

7.28 (6.06–8.49)

108/2531

4.27 (3.48–5.05)

5.71 (4.62–6.79)

Prediabetes (IFG or IGT)

126/1000

12.60 (10.54–14.66)

7.95 (6.55–9.36)

88/1040

8.46 (6.77–10.15)

6.62 (5.06–8.19)

DM

133/536

24.81 (21.15–28.47)

13.10 (9.83–16.38)

156/720

21.67 (18.65–24.68)

10.67 (8.90–12.44)

Total

398/3427

11.61 (10.54–12.69)

8.62 (7.81–9.44)

352/4291

8.20 (7.38–9.02)

7.19 (6.46–7.93)

  1. NFG Normal fasting glucose, NGT Normal glucose tolerance, IFG Impaired fasting glucose, IGT Impaired glucose tolerance, DM Diabetes mellitus, CI Confidence interval
  2. aAge-standardized prevalence is calculated based on Iranian population distribution data from the National Consensus Bureau for Tehran province (2010)